News
IDIBELL researchers look for new drugs against melanoma
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) participated in a study published recently in the by the journal Investigative Dermatology, entitled “AURORA A overexpression (AURKA) is driven by FOXM1 and MAPK / ERK activation in melanoma cells harbouring BRAF or NRAS mutations: Impact […]
Bellvitge research receives 1 million euros in PERIS 2016-2020 funding
The Department of Health has issued the final resolution of the first call for research grants linked to the Strategic Plan for Research and Innovation in Health (PERIS) 2016-2020. Researchers from the University Hospital of Bellvitge (HUB), the Catalan Institute of Oncology (ICO) and the University of Barcelona (UB) and their research projects, managed through […]
An epigenetic lesion could be responsible for acute T-cell leukemia
Researchers from the Epigenetics and Cancer Biology Program (PEBC) led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute (IDIBELL) have discovered how an epigenetic lesion can lead to T-cell acute lymphoblastic leukemia. The article, published in the journal Leukemia, leader in the field of hematology, correlates the lesion with the activation of a […]
The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer
Recent research results from the TGF-beta and cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL), within IT-Liver, a collaborative European action among several research groups led by Dr. Isabel Fabregat, provide a better understanding of the role of the TGF-beta cytokine in liver cancer. Their work, published in Cancer Letters, shows how the […]
The research in Neurofibromatosis receives again the support of the city of Manlleu
The 2nd floor of the parking under Manlleu Square was filled with people, on February 12, to enjoy the Solidarity Underground Festival for the Neurofibromatosis research, organized by the Health Center Fitness Spa and Health Fina 67 study, jointly with the Catalan Association of Neurofibromatosis (ACNefi). During the day, which was very successful, workshops, a […]
After the epigenome: the epitranscriptome
Our genome is made up of 6,000 million pieces of DNA that combine four “flavors”: A, C, G and T (Adenine, Cytosine, Guanine and Thymine). It is our Alphabet. But to this base we must add some regulation, just like the spelling and grammar of that alphabet: this is what we call Epigenetics. In epigenetics, […]
The second edition of IDIBELL PhD day highlights the potential of young researchers
The PhD day also engages l’Hospitalet citizens
ICS visits IDIBELL
Last Thursday, March 16th, an official visit of representatives of the Scientific and Research Directorate of the Catalan Health Institute (ICS) took place at the Bellvitge Biomedical Research Institute (IDIBELL). This visit is part of the programme that the Scientific and Research Directorate of ICS carries out to get involved with its linked Health Research […]
Cryopreserved orthoxenografts broaden the scope of single cell sequencing technologies
Researchers from Bellvitge Biomedical Research Institute (IDIBELL) – Catalan Institute of Oncology (ICO), led by Dr. Alberto Villanueva, and Bellvitge University Hospital (Dr August Vidal) have contributed to a study carried out by Centro Nacional de Análisis Genómico (CNAG-CRG) that has substantially broadened the applicability of single cell genomics by combining cell and tissue cryopreservation […]